| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $34.4M | +9.6% |
| Cost of Revenue | $23.0M | +6.4% |
| Gross Profit | $11.4M | +16.7% |
| R&D Expense | $116K | +43.0% |
| SG&A Expense | $172K | -12.7% |
| Operating Income | $5.5M | +33.2% |
| Pre-tax Income | $6.7M | +28.1% |
| Income Tax | $2.4M | +46.6% |
| Net Income | $3.4M |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.7M | +64.4% |
| Short-term Investments | $1.0M | +2.5% |
| Accounts Receivable | $7.1M | +21.0% |
| Inventory | $9.5M | +13.5% |
| Current Assets | $23.8M | +25.1% |
| Total Assets | $39.6M | +12.7% |
| Current Liabilities | $9.8M | +24.5% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $4.5M | -20.5% |
| Capital Expenditures | $782K | -27.0% |
| Investing Cash Flow | -$660K | +79.5% |
| Financing Cash Flow | -$1.7M | +36.6% |
| Free Cash Flow | $3.8M | -19.0% |
| +15.9% |
| Long-term Debt |
| $2.4M |
| -38.5% |
| Total Liabilities | $11.8M | +4.7% |
| Stockholders' Equity | $25.1M | +18.4% |